The Quintuple Aim: A New Direction for Healthcare Improvement

By Michael Awood

October 26, 2023

Illustration of the Quintuple Aim framework in healthcare, highlighting the five aims: improving population health, enhancing care experience, cost efficiency, provider wellbeing, and health equity.

The healthcare industry has faced significant challenges recently which has led to escalating costs. These have also continued to expand the disparities within healthcare worldwide. The COVID-19 pandemic brought these to light, with the marginalised communities experiencing higher rates of infection, morbidity, and mortality. These communities also continued to experience greater care disruptions. But what can be done about this? How could technology look to improve the outcomes and provide value? The quintuple framework proposes valuable aspects to improve healthcare systems and coupled with this, AI technologies can look to scale these improvements.

 

The Quintuple Aim

The need to optimise healthcare outcomes and reduce economic waste is more critical than ever. The triple aim was introduced as a beacon to guide healthcare improvements, focusing on enhancing population health, improving care experience, and promoting cost efficiency. However, the rising burnout rates among physicians and the increasing desire to leave the industry necessitated the inclusion of a fourth aim: addressing provider well-being. Without this, quality improvements would be unsustainable. The fifth aim was updated to include health equity, which ensures that we explicitly address equity and actively explore new efforts to promote it.

The quintuple aims for healthcare improvement are:

  1. Improving population health
  2. Enhancing care experience
  3. Cost Efficiency
  4. Provider Wellbeing
  5. Health Equity

 

The Role of Technology and Policy

Technology, particularly AI, plays a crucial role in achieving these aims. AI can improve access to equitable health, ensure cost-effectiveness through predictive algorithms, and manage procedural or administrative work through virtual assistants. Oracle Health has recently shown its new work in the healthcare space and optimising clinical models through the use of LMMs (multimodal models), by launching their digital assistant. The view is that it reduces the cognitive load on clinicians optimising the clinical delivery process, which ultimately also keeps it human. In turn, improvements to patient safety (increased clinician awareness), experience, and provider well-being are immediately actualised. These in turn allow for the other aims to occur as a direct outcome of these enhancements.

Policies based on these principles are essential for designing effective economic supports. Through explainable AI systems, value-based care incentives, and appropriate demographic data, outcomes can be improved, and care can be enhanced in any resource setting.

 

Cover image taken from: Chess Health Solutions

Reference url

Recent Posts

EUDAMED Implementation 2026
EUDAMED Implementation 2026: Key Changes and National Adaptations

By HEOR Staff Writer

May 22, 2026

The EUDAMED Implementation 2026 will require mandatory use of four key modules in the European database on medical devices from 28 May 2026. These cover registration of economic operators, device registration via UDI, notified bodies and certificates, plus market surveillance, following earlier v...
TrumpRx.gov expansion
TrumpRx.gov Expansion: Enhancing Medication Price Transparency and Competition
TrumpRx.gov expansion marks a major step toward greater medication price transparency, as detailed in President Donald J. Trump’s announcement to list more than 600 generic drugs on the platform. Patients can now compare competitive cash prices from Amazon Pharmacy, Cost Plus Drugs, and GoodRx fo...
Portugal health spending 2025
Portugal Health Spending 2025 Reaches Record €4.417 Billion Amid Rising Demand
Portugal health spending 2025 hit a fresh peak as the country’s publicly funded National Health Service recorded its highest annual outlay on medicines, reaching €4.417 billion according to Infarmed data. This total, already net of industry rebates and contributions, was propelled chiefly by expa...